Back to Search
Start Over
OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE
- Source :
- Digestive and Liver Disease. 54:S93-S94
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Hepatology
Gastroenterology
Subjects
Details
- ISSN :
- 15908658
- Volume :
- 54
- Database :
- OpenAIRE
- Journal :
- Digestive and Liver Disease
- Accession number :
- edsair.doi...........f36ee073856fa86b3eb84e8e275eb5af
- Full Text :
- https://doi.org/10.1016/s1590-8658(22)00328-0